Quarterly report [Sections 13 or 15(d)]

Schedule of Segment Financial Information (Details)

v3.26.3
Schedule of Segment Financial Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting [Line Items]                
Net sales $ 74,137         $ 74,137
Cost of sales (34,008)         (34,008)
Gross profit 40,129         40,129
Operating expenses:                
Total research and development 143,294     504,387     739,581 2,403,363
Total selling, general and administrative 2,755,334     1,256,284     7,098,996 3,469,842
Interest income 37,099     68,682     162,279 176,536
Net loss (2,821,400) $ (2,967,063) $ (1,847,706) (1,691,989) $ (1,701,093) $ (2,303,587) (7,636,169) (5,696,669)
Single Reportable Segment [Member]                
Segment Reporting [Line Items]                
Net sales 74,137         74,137
Cost of sales (34,008)         (34,008)
Gross profit 40,129         40,129
Operating expenses:                
Total research and development 143,294     504,387     739,581 2,403,363
Total selling, general and administrative 2,755,334     1,256,284     7,098,996 3,469,842
Interest income 37,099     68,682     162,279 176,536
Net loss (2,821,400)     (1,691,989)     (7,636,169) (5,696,669)
Single Reportable Segment [Member] | Clinincal [Member]                
Operating expenses:                
Total research and development         78,263 705,645
Single Reportable Segment [Member] | Chemistry Manufacturing And Controls [Member]                
Operating expenses:                
Total research and development 35,811     36,274     96,068 320,104
Single Reportable Segment [Member] | Personnel Related [Member]                
Operating expenses:                
Total research and development 107,483     468,113     565,250 1,377,614
Total selling, general and administrative 759,858     331,360     1,840,306 1,070,255
Single Reportable Segment [Member] | Compliance [Member]                
Operating expenses:                
Total selling, general and administrative 409,501     344,290     1,541,650 1,472,750
Single Reportable Segment [Member] | Legal Expense [Member]                
Operating expenses:                
Total selling, general and administrative 926,945     107,694     2,030,000 453,897
Single Reportable Segment [Member] | Marketing Expense [Member]                
Operating expenses:                
Total selling, general and administrative 545,178     472,940     1,444,241 472,940
Single Reportable Segment [Member] | Commercial Readiness [Member]                
Operating expenses:                
Total selling, general and administrative $ 113,852         $ 242,799